Evidence map›Paper›PMID 42177475›Full record

ArticleBMC ophthalmology2026

Evaluation of epithelial, stromal, and corneal thickness maps in the distinction between pellucid marginal degeneration and inferior keratoconus (pellucid-like).

Büşra Dilara Yıldırım Erdal, Burcu Kazancı

Abstract read
In one paragraph

Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Büşra Dilara Yıldırım ErdalDepartment of Ophthalmology, Ankara Etlik City Hospital, Ankara, Turkey. ybusradilara@gmail.com.
Burcu KazancıDepartment of Ophthalmology, Ankara Etlik City Hospital, Ankara, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo distinguish between these two ectasias, which can be confused with each other, using epithelial, stromal, and total corneal thickness maps in patients with pellucid marginal degeneration (PMD) and inferior keratoconus (I-KC) that have similar topographic features.

methodsThis prospective cross-sectional study included 114 eyes of 73 patients (56 eyes with PMD, 58 eyes with I-KC). All measurements were obtained using MS-39 AS-OCT. The values in the epithelial, stromal, and corneal thickness maps were recorded.

resultsThere was no significant difference in mean age between the two groups (p = 0.061). In PMD patients, minimum epithelial, stromal, and total corneal thickness values in the inferotemporal (IT), inferior (I), inferonasal (IN), and nasal (N) zones within 6-8 mm and 8-10 mm areas were significantly thinner than in the I-KC group (p < 0.05). In the I-KC group, minimum and average epithelial thickness values in the central 2 mm area, in the IT and temporal (T) zones within 2-4 mm areas, and in the IT zone within 4-6 mm areas were significantly thinner than in the PMD group (p < 0.05). To distinguish PMD from I-KC, the IT 2-4 min./IN 8-10 min.

conclusionsPatients exhibiting crab-claw patterns on the sagittal curvature map can differentiate between PMD and I-KC using pachymetric values and combinations of epithelial, stromal, and corneal thickness maps obtained with wide-field AS-OCT.

Indexed as

CorneaCorneal Dystrophies, HereditaryCorneal StromaEpithelium, CornealKeratoconusAdolescentAdultCorneal PachymetryCorneal TopographyCross-Sectional StudiesDiagnosis, DifferentialFemaleHumansMaleMiddle AgedProspective StudiesCrab-claw patternEpithelial thickness mapInferior keratoconusPellucid marginal degenerationStromal thickness map

Identifiers

PMID42177475
PMCPMC13390431

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.